KHN analysis: The revolving door between Capitol Hill and the drug industry
KHN analysis showed that more than a dozen former drug industry employees now have jobs on Capitol Hill — often on committees that handle health care policy.
Are pharma industry companies converting patients with orphan diseases into lobbyists?
Behind-the-scenes partnerships between the pharmaceutical industry and advocacy groups may work against lowering the cost of high-priced drugs.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.